Zacks Research Has Pessimistic Outlook of STERIS Q2 Earnings

STERIS plc (NYSE:STE – Free Report) – Equities researchers at Zacks Research decreased their Q2 2026 earnings estimates for STERIS in a research report issued to clients and investors on Tuesday, September 16th. Zacks Research analyst Team now forecasts that the medical equipment provider will post earnings of $2.37 per share for the quarter, down […]

Leave a Reply

Your email address will not be published.

Previous post Q2 EPS Estimate for Orion Energy Systems Reduced by Analyst
Next post Valley National Bancorp (NASDAQ:VLY) Rating Lowered to “Sell” at Wall Street Zen